Projects

Presentation, tReatments, challenges and Opportunities for optimal Treatments in the Elderly with select Chronic condiTions (PROTECT) Study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - Ongoing

Project Lead

Dr. Denis Xavier

Authors

PI: Dr. Atiya R. Faruqui, Co-I: Dr. Arvind Kasthuri, Dr. Denis Xavier, Dr. Jonita, Dr. Pretesh Kiran

Project Status

ongoing